Dasatinib induces lung vascular toxicity and predisposes to pulmonary hypertension
Carole Phan (Le Plessis-Robinson, France), Carole Phan, Andrei Seferian, Alice Huertas, Ly Tu, Raphael Thuillet, Caroline Sattler, Morane Le Hiress, Yuichi Tamura, Etienne-Marie Jutant, Marie-Camille Chaumais, Stéphane Bouchet, Benjamin Manéglier, Mathieu Molimard, Philippe Rousselot, Olivier Sitbon, Gérald Simonneau, David Montani, Marc Humbert, Christophe Guignabert
Source: International Congress 2016 – Clinic of pulmonary hypertension
Session: Clinic of pulmonary hypertension
Session type: Oral Presentation
Number: 262
Disease area: Pulmonary vascular diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Carole Phan (Le Plessis-Robinson, France), Carole Phan, Andrei Seferian, Alice Huertas, Ly Tu, Raphael Thuillet, Caroline Sattler, Morane Le Hiress, Yuichi Tamura, Etienne-Marie Jutant, Marie-Camille Chaumais, Stéphane Bouchet, Benjamin Manéglier, Mathieu Molimard, Philippe Rousselot, Olivier Sitbon, Gérald Simonneau, David Montani, Marc Humbert, Christophe Guignabert. Dasatinib induces lung vascular toxicity and predisposes to pulmonary hypertension. Eur Respir J 2016; 48: Suppl. 60, 262
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: